Physician profile
Joseph Daniel Edwards, JR.
NPI 1255408332
$1,630.81
in general payments reported to CMS, 2019-2025
18 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $225 · 2021: $151 · 2022: $307 · 2023: $284 · 2024: $279 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $267.82 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $262.12 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $254.36 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $147.82 | 2020-2022 | |
| Glaxosmithkline, LLC. | $143.06 | 2019-2025 | Pediarix, Bexsero |
| Sanofi Pasteur INC. | $114.20 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $81.25 | 2020-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $66.03 | 2022-2023 | Qelbree |
| Neos Therapeutics, LP | $60.77 | 2019-2020 | |
| Pfizer INC. | $59.80 | 2019-2023 | |
| Collegium Pharmaceutical, INC. | $50.97 | 2025 | Jornay Pm |
| Seqirus USA INC | $34.92 | 2022-2024 | Flucelvax |
| Shire North American Group INC | $24.82 | 2019 | |
| Genentech USA, INC. | $15.97 | 2019 | |
| Allergan, INC. | $12.79 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $11.63 | 2020 | |
| Mission Pharmacal Company | $11.29 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.